Rhenman & Partners Asset Management Ab Portfolio Holdings
Rhenman & Partners Asset Management Ab
- $840 Million
- Q1 2025
Rhenman & Partners Asset Management Ab has filed its 13F form on May 14, 2025 for Q1 2025 where it was disclosed a total value porftolio of $840 Million distributed in 94 stocks.
Among their holdings, we can observe that their the top five positions include companies like: Unitedhealth Group Inc with a value of $40.6M, Eli Lilly & CO with a value of $34.5M, Vertex Pharmaceuticals Inc with a value of $32.4M, Mckesson Corp with a value of $31.8M, and Boston Scientific Corp with a value of $30.3M.
Examining the 13F form we can see an decrease of $119M in the current position value, from $959M to 840M.
Rhenman & Partners Asset Management Ab is based out at Stockholm, V7
Below you can find more details about Rhenman & Partners Asset Management Ab portfolio as well as his latest detailed transactions.